drugset / Trial / NCT05297513

Efficacy of ActiveMatrix on Spinal SSI Rate

NCT05297513

Phase 4 Not yet recruiting 275 enrolled Baylor College of Medicine Skye Biologics Holdings, LLC · collab
RandomizedParallel-groupSingle-blindPrevention

Summary

This clinical trial seeks to provide high level of evidence on the efficacy of ActiveMatrix primarily on spinal surgical site infection rate.

Timeline

Start
2022-07
Primary completion
2025-07
Completion
2026-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject ActiveMatrix Other / unclassified Topical